VXRT insider filings
Vaxart, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-20. Screen VXRT transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 2 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Bono Raquel C. — Director | 2 | — | — | 2 |
Recent insider filings — Vaxart, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-20 | 4 | Bono Raquel C. — Director | Grant/award (A): 78,800 @ $0 · Grant/award (A): 157,400 (derivative) @ $0 | EDGAR |
| 2026-10-20 | 3 | Bono Raquel C. — Director | Holdings only — no transactions reported | EDGAR |
| 2026-07-20 | 4 | Finney Kevin — Director | Grant/award (A): 39,400 @ $0 · Grant/award (A): 78,700 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Wheadon David E. — Director | Grant/award (A): 39,400 @ $0 · Grant/award (A): 78,700 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Watson W. Mark — Director | Grant/award (A): 39,400 @ $0 · Grant/award (A): 78,700 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | BREITMEYER JAMES B — Director | Grant/award (A): 8,315 @ $0 · Grant/award (A): 16,610 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | HERON ELAINE J — Director | Grant/award (A): 39,400 @ $0 · Grant/award (A): 78,700 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | Watson W. Mark — Director | Purchase (P): 10,000 @ $0.65 | EDGAR |
| 2026-05-21 | 4 | Grasman Jeroen Nicolaas — Chief Financial Officer | Tax withholding (F): 31,395 @ $0.61 | EDGAR |
| 2026-05-01 | 4 | BREITMEYER JAMES B — Director | Grant/award (A): 78,800 @ $0 · Grant/award (A): 157,400 (derivative) @ $0 | EDGAR |
| 2026-03-31 | 4 | Cummings James F. — Chief Medical Officer | Tax withholding (F): 3,292 @ $0.65 | EDGAR |
| 2026-03-31 | 4 | Tucker Sean — SVP, Chief Scientific Officer | Tax withholding (F): 3,924 @ $0.65 | EDGAR |
| 2026-03-26 | 4 | Berg Edward B — SVP, General Counsel | Tax withholding (F): 36,418 @ $0.69 | EDGAR |
| 2026-03-26 | 4 | Cummings James F. — Chief Medical Officer | Tax withholding (F): 30,551 @ $0.69 | EDGAR |
| 2026-03-26 | 4 | Tucker Sean — SVP, Chief Scientific Officer | Tax withholding (F): 36,418 @ $0.69 | EDGAR |
| 2026-03-26 | 4 | Lo Steven — President, Chief Exec Officer, Director | Tax withholding (F): 126,028 @ $0.69 | EDGAR |
| 2026-03-20 | 4 | Berg Edward B — SVP, General Counsel | Tax withholding (F): 8,072 @ $0.63 | EDGAR |
| 2026-03-20 | 4 | Cummings James F. — Chief Medical Officer | Tax withholding (F): 6,772 @ $0.63 | EDGAR |
| 2026-03-20 | 4 | Tucker Sean — SVP, Chief Scientific Officer | Tax withholding (F): 8,072 @ $0.63 | EDGAR |
| 2026-03-20 | 4 | Lo Steven — President, Chief Exec Officer, Director | Tax withholding (F): 22,425 @ $0.63 | EDGAR |
| 2026-03-18 | 4 | Grasman Jeroen Nicolaas — Chief Financial Officer | Grant/award (A): 227,000 @ $0 · Grant/award (A): 455,000 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4 | Berg Edward B — SVP, General Counsel | Grant/award (A): 115,000 @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4 | Cummings James F. — Chief Medical Officer | Grant/award (A): 227,000 @ $0 · Grant/award (A): 455,000 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4 | Tucker Sean — SVP, Chief Scientific Officer | Grant/award (A): 200,000 @ $0 · Grant/award (A): 410,000 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4 | Lo Steven — President, Chief Exec Officer, Director | Grant/award (A): 846,500 @ $0 · Grant/award (A): 1,543,000 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Berg Edward B — SVP, General Counsel | Tax withholding (F): 9,265 @ $0.61 | EDGAR |
| 2026-02-05 | 4 | Cummings James F. — Chief Medical Officer | Tax withholding (F): 7,965 @ $0.61 | EDGAR |
| 2026-02-05 | 4 | Tucker Sean — SVP, Chief Scientific Officer | Tax withholding (F): 9,265 @ $0.61 | EDGAR |
| 2025-12-08 | 4 | Lo Steven — President, Chief Exec Officer, Director | Grant/award (A): 151,351 @ $0 · Tax withholding (F): 54,153 @ $0.37 | EDGAR |
| 2025-12-05 | 4 | Watson W. Mark — Director | Purchase (P): 15,000 @ $0.41 · Purchase (P): 5,000 @ $0.41 | EDGAR |
| 2025-11-21 | 4 | HERON ELAINE J — Director | Purchase (P): 23,217 @ $0.39 · Purchase (P): 16,783 @ $0.41 | EDGAR |
| 2025-08-19 | 4 | Finney Kevin — Director | Purchase (P): 794 @ $0.38 · Purchase (P): 20,000 @ $0.39 · Purchase (P): 20,000 @ $0.40 · Purchase (P): 25,874 @ $0.38 · Purchase (P): 50,000 @ $0.35 · Purchase (P): 50,000 @ $0.37 | EDGAR |
| 2025-07-31 | 4 | Watson W. Mark — Director | Purchase (P): 10,000 @ $0.41 | EDGAR |
| 2025-06-16 | 4 | Finney Kevin — Director | Grant/award (A): 6,103 @ $0 · Grant/award (A): 36,392 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Wheadon David E. — Director | Grant/award (A): 16,000 @ $0 · Grant/award (A): 95,400 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Finney Michael J. — Director | Grant/award (A): 16,000 @ $0 · Grant/award (A): 95,400 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Watson W. Mark — Director | Grant/award (A): 16,000 @ $0 · Grant/award (A): 95,400 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | HERON ELAINE J — Director | Grant/award (A): 16,000 @ $0 · Grant/award (A): 95,400 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Grasman Jeroen Nicolaas — Chief Financial Officer | Grant/award (A): 350,000 @ $0 · Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Lo Steven — President, Chief Exec Officer, Director | Purchase (P): 100,000 @ $0.49 | EDGAR |
| 2025-04-01 | 4 | Cummings James F. — Chief Medical Officer | Tax withholding (F): 3,292 @ $0.42 | EDGAR |
| 2025-04-01 | 4 | Tucker Sean — SVP, Chief Scientific Officer | Tax withholding (F): 3,913 @ $0.42 | EDGAR |
| 2025-03-26 | 4 | Lee Phillip E — Chief Financial Officer | Grant/award (A): 406,000 @ $0 · Grant/award (A): 610,000 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | Berg Edward B — SVP, General Counsel | Grant/award (A): 406,000 @ $0 · Grant/award (A): 610,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | Cummings James F. — Chief Medical Officer | Grant/award (A): 406,000 @ $0 · Grant/award (A): 610,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | Tucker Sean — SVP, Chief Scientific Officer | Grant/award (A): 406,000 @ $0 · Grant/award (A): 610,000 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | Lo Steven — President, Chief Exec Officer, Director | Grant/award (A): 1,405,000 @ $0 · Grant/award (A): 2,108,000 (derivative) @ $0 | EDGAR |
| 2025-03-20 | 4 | Cummings James F. — Chief Medical Officer | Tax withholding (F): 3,267 @ $0.75 · Tax withholding (F): 6,772 @ $0.57 | EDGAR |
| 2025-03-20 | 4 | Tucker Sean — SVP, Chief Scientific Officer | Tax withholding (F): 8,050 @ $0.57 | EDGAR |
| 2025-03-20 | 4 | Lo Steven — President, Chief Exec Officer, Director | Tax withholding (F): 22,362 @ $0.57 | EDGAR |
Recent 8-K events — Vaxart, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-14 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-25 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-28 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VXRT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs